![](/img/cover-not-exists.png)
A decline in circulating HER2 DNA predicts treatment response and survival in breast cancer patients treated with trastuzumab
B. Sorensen, L.S. Mortensen, J. Andersen, E. NexoVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)71600-8
File:
PDF, 88 KB
english, 2008